Dr. Anne Stevens of the University of Washington, Seattle Children’s Hospital discusses her study to evaluate the role of the protein PD-L1 to help doctors determine whether an illness is lupus-related or the result of an infection.
News & Stories
For years, researchers have investigated the possibility of inhibiting the actions of lupus-related autoantibodies to reduce the extent of organ damage. Further research in this area has the potential to facilitate the development of new therapies for people with lupus.
The researchers studied the relationship between anti-NR2A antibodies and different aspects of lupus, especially whether there might be a relationship between these antibodies and NPSLE in patients from Japan.
Dr. Joseph McCune of the University of Michigan discusses the role interferon and endothelial cells, which line blood vessels, as possible causes of increased risk of heart attacks and strokes associated with lupus.
Our Annual Lupus Symposium in Augusta has moved to March 22, 2014!